Back

Routine HbA1c screening identifies de novo (pre)diabetes mellitus in 37% of ACS patients which comes with an even higher ischemic risk compared to known diabetes mellitus

31 August 2024 (15:00 - 15:50)
Organised by: Logo
Congress Presentation Part of: Risk factors, risk scores, and outcomes after acute coronary syndromes Epidemiology, Prognosis, Outcome ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Ms Sanne Janssen

Zuyderland Medical Centre, Heerlen (Netherlands (The))

8 More presentations in this session

Presentation thumbnail
Unraveling the paradox: the impact of one or more traditional risk factors on short-term mortality following acute coronary syndromes.
Doctor M. Bergami (Bologna, IT)
Abstract Slides Video
Presentation thumbnail
Comparison of GRACE and TIMI risk scores in the prediction of in hospital outcome among NSTEMI patients: a single centre study
Doctor M. CHOWDHURY (Dhaka, BD)
Abstract Slides Video
Presentation thumbnail
Association of polymorphism of apolipoprotein e gene with acute myocardial infarction and its short term clinical outcome
Professor M. Chaliha (Assam, IN)
Abstract Slides Video
Presentation thumbnail
Nomogram-based prediction of MACE in older adults with STEMI
Doctor A. Hernandez (Storrs, US)
Abstract Slides Video
Presentation thumbnail
Baseline shock index-creatinine clearance score and long-term mortality after ACS. Results from 24 years of follow-up of the ABC study on heart disease.
Doctor G. Berton (Conegliano, IT)
Abstract Slides Video

Access the full session

Session thumbnail
Risk factors, risk scores, and outcomes after acute coronary syndromes

The Event

Event poster

ESC Congress 2024

31 August 2024 15:00 CET
You may be interested in
thumbnail
Congress Presentation
Undiagnosed Diabetes Mellitus is an important risk factor in secondary prevention after an acute coronary syndrome and warrants active screening
thumbnail
Congress Presentation
Impact of prediabetes on long-term outcomes after percutaneous coronary interventions
thumbnail
Congress Presentation
Diabetes and prediabetes prevalence and guideline directed antidiabetic therapy in acute coronary syndrome and complex coronary interventions

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources